Advertisement

Related Videos

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Deborah Collyar: What's In It for Patients?

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Advertisement

Advertisement




Jun
04
Today In Oncology
Annual Galleri Screening Reduced Stage IV Cancer Diagnoses but Missed Primary Endpoint in First Randomized MCED Trial
GLP-1 RAs Associated With Lower Breast Cancer Incidence
American Cancer Society Updates Colorectal Cancer Screening Guideline
Long-Term Follow-Up of Three First-Line Regimens in Mantle Cell Lymphoma
Does Tissue TMB Outperform Blood-Based Testing for Predicting Immunotherapy Response
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo